Posted on: 30 October, 2020
Acid exposure reflux monitoring predicted the ability to discontinue proton pump inhibitor use without symptom escalation among patients with gastroesophageal reflux disease and inadequate proton pump inhibitor response.
Read More
Source: Healio
